We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Motif Bio Plc | LSE:MTFB | London | Ordinary Share | GB00BVVT4H71 | ORD 0.01P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.50 | 0.40 | 0.55 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
04/10/2017 08:55 | It often takes a day or two for news to percolate through the decision making process for those investing significant sums. A series of nice big white candlesticks is now on the cards. Sit back and relax is my advice. | longshanks | |
04/10/2017 08:52 | Wonder what goodies they will have for this afternoons conference call.... | blueblood | |
04/10/2017 08:50 | I bet AMP is still selling but a more sustained rise is on the cards once out of the way | gersemi | |
04/10/2017 08:47 | this muted rise is crazzzy... should be up 100% for starters, hopefully the yanks will understand!! | pjj71 | |
04/10/2017 08:42 | 'clinicians project that iclaprim, if approved, could potentially displace standard of care IV Gram-positive antibiotic therapies, such as vancomycin, in empiric treatment of MRSA-suspected ABSSSI patients with renal impairment.'... - | gersemi | |
04/10/2017 08:40 | Can't wait until NASDAQ opens to see proper valuation... | blueblood | |
04/10/2017 08:35 | Let's see what Hardman and Beaufort have to say... anyone selling now is a muppet..this company is now virtually derisked with FDA approval in 6 months | gersemi | |
04/10/2017 08:34 | Fast track should lead to approval within 6 months. Be interesting to see Nasdaq reaction. Topped up at 46p | waterloo01 | |
04/10/2017 08:32 | How much is 10 year exclusivity worth? | babbler | |
04/10/2017 08:28 | Book... Probably... But they have the ability to negotiate with that news... So imo won't be cheap. | babbler | |
04/10/2017 08:28 | They do need cash but it could come just as easily from a licensing deal as a fundraising. AMP seem confident that waiting until January before selling any more shares is a good idea. I am inclined to agree with them. | longshanks | |
04/10/2017 08:25 | Fund raising next? | bookbroker | |
04/10/2017 08:22 | BOOM BOOM GUYS | falia | |
04/10/2017 08:20 | That dip should have scared off the day traders so this looks like a good time to top up for me | return_of_the_apeman | |
04/10/2017 08:09 | Lol bet he will be here soon, this news is worth £1+ today | return_of_the_apeman | |
04/10/2017 08:08 | You got them cheap savvy | longshanks | |
04/10/2017 08:07 | What no falia?? | babbler | |
04/10/2017 08:06 | Finally got a few more but had to pay 46p! | 1savvyinvestor | |
04/10/2017 08:04 | Cant buy any. Grrrrrrr. | encarter | |
04/10/2017 08:02 | It's in auction | gersemi | |
04/10/2017 08:01 | Trying to add but can't ! | 1savvyinvestor | |
04/10/2017 07:56 | Great timing not by AMP too | blueblood | |
04/10/2017 07:52 | With Amphion (distressed seller) out of the way we should see minimal drag from a previous heavy seller | gersemi | |
04/10/2017 07:52 | Great news - now let's see an IMM like day (+40%)! | adorling | |
04/10/2017 07:52 | So I was a day early with my "This feels like it's about ready to blow!" comment yesterday! | parob |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions